Pegfilgrastim Biosimilars Market

Pegfilgrastim Biosimilars Market Share, Size, Growth 2023-2031

Posted by

The ‘Global Pegfilgrastim Biosimilars Market Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global pegfilgrastim biosimilars market analysis, assessing the market on the basis of its segments like indication type, product type, application, distribution channel, and major regions.

The report also provides a detailed insight of the market on the basis of patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnership and collaborations analysis.

Pegfilgrastim Biosimilars Market Share, Size, Price, Growth, Trends, Industry Report, Key Player, Major Segments and Forecast

The key highlights of the report include:

Market Overview (2016-2031)

  • Forecast CAGR (2023-2031): 7%

Growing demand for cost-effective alternatives to biologic drugs is expected to drive the growth of the global pegfilgrastim biosimilars market. The increasing prevalence of cancer and the need for supportive care treatments like neutropenia management offer lucrative growth opportunities to the market. However, challenges in manufacturing processes and regulatory complexities might pose challenges for the pegfilgrastim biosimilars market.

Get a Free Sample Report with Table of Contents@

The patent expiration of Neulasta®, a pegfilgrastim drug produced by Amgen, has led to the development of various biosimilars, opening new growth opportunities for the market. These developments, coupled with the growing demand for affordable treatments and strengthening healthcare infrastructure, are likely to contribute to the global pegfilgrastim biosimilars market growth.

Pegfilgrastim Biosimilars Industry Definition and Major Segments

Pegfilgrastim is a PEGylated form of recombinant human granulocyte colony-stimulating factor (G-CSF) analog filgrastim. It is used to stimulate the production of white blood cells, specifically neutrophils, to reduce the risk of infection in patients undergoing chemotherapy. Pegfilgrastim biosimilars are highly similar versions of the original pegfilgrastim drugs, with no clinically meaningful differences in terms of safety and efficacy.

Read Full Report with Table of Contents@

Based on indication type, the market is segmented into:

  • Neutropenia
  • Hematopoietic Subsyndrome
  • Others

Based on product type, the market is segmented into:

  • MK-6302
  • Peg G-CSF
  • PEG Neutrogena
  • Grasustek
  • LA-EP2006
  • R-TPR-029
  • Filgrastim
  • Others

Based on application, the market is classified into:

  • Oncology
  • Chronic and Autoimmune Diseases
  • Others

Based on distribution channel, the market is bifurcated into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Based on region, the market is segregated into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Pegfilgrastim Biosimilars Market Trends

The key trends in the global pegfilgrastim biosimilars market include the growing development and research by the pharmaceutical sector, aimed towards the development of affordable biosimilar drugs. Increased clinical trials for pegfilgrastim biosimilars are projected to drive market growth. Additionally, strategic collaborations between pharmaceutical companies to enhance their biosimilars portfolio are anticipated to impact the growth of the market positively.

The rising prevalence of cancer and the increasing demand for cost-effective treatment options are major factors driving the pegfilgrastim biosimilars market. In addition, favorable government policies and initiatives to promote the use of biosimilars are expected to boost the growth of the market.

Key Market Players

The major players in the global pegfilgrastim biosimilars market report are Merck & Co., Inc., Biocon Limited, Sandoz International GmbH, Intas Pharmaceuticals Ltd., Mylan N.V., Fresenius Kabi AG, Apotex Inc., and Pfizer Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.

The report studies the latest updates in the market, along with their impact across the market. It also analyzes the market demand, together with its price and demand indicators. The report also tracks the market based on SWOT and Porter’s Five Forces Models.

About Us:

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.

Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.

Media Contact:

Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

Leave a Reply

Your email address will not be published. Required fields are marked *